Concepedia

Publication | Open Access

Talimogene laherparepvec (T-VEC) in combination (combo) with ipilimumab (ipi) versus ipi alone for advanced melanoma: 3-year landmark analysis of a randomized, open-label, phase II trial

10

Citations

0

References

2019

Year

No additional data available for this publication yet. Check back later!